Prime Discoveries

Executive Summary

Prime Discoveries is a US-based diagnostics company founded in 2019 and headquartered in Cambridge, Massachusetts. The company develops and supplies rapid, scalable molecular diagnostic panels for laboratories, initially focusing on COVID-19 and its variants. It has since expanded its portfolio to include panels for respiratory infections, sexually transmitted infections (STIs), and emerging pathogens like Candida auris. By targeting high-demand areas in infectious disease diagnostics, Prime Discoveries addresses the growing need for rapid, multiplex testing solutions in clinical and public health settings. The company operates in a competitive but expanding market, with opportunities for growth as healthcare systems prioritize decentralized testing and pandemic preparedness.

Upcoming Catalysts (preview)

• Q2 2026FDA 510(k) clearance for expanded respiratory panel75% success
• Q3 2026Commercial launch of next-generation STI panel65% success
• Q4 2026Strategic partnership with a major hospital network50% success